Researchers at VHIO have published an article in the journal European Journal of Cancer on the evolution of targeted therapies…
Fundación FERO
Co-led by Rodrigo Toledo and Elena Garralda, IMMUNOMICS-VHIO is a platform for the discovery and validation of liquid biopsy biomarkers…
As it does every spring, this past weekend — May 31st and June 1st — the Festa de la Ciència…
Co-authored by investigators of VHIO’s Cancer Genomics Group and Research Unit for Molecular Therapy of Cancer (UITM) – CaixaResearch, results…
Dr. Mate Maus, head of the Aging and Cancer Group at VHIO, has been awarded the XXVIII FERO Grant for…
The ultrasensitive liquid biopsy technique applied in this work is based on the sequencing of the entire tumour genome from…
